Percutaneous collagen induction. Scarless skin rejuvenation:fact or fiction?

Research output: Contribution to journalArticleResearchpeer review

Authors

  • M. C. Aust
  • K. Reimers
  • A. Gohritz
  • S. Jahn
  • F. Stahl
  • T. Scheper

Research Organisations

External Research Organisations

  • Hannover Medical School (MHH)
  • DIAKOVERE Friederikenstift Hannover
Plum Print visual indicator of research metrics
  • Citations
    • Citation Indexes: 58
  • Captures
    • Readers: 59
see details

Details

Original languageEnglish
Pages (from-to)437-439
Number of pages3
JournalClinical and Experimental Dermatology
Volume35
Issue number4
Publication statusPublished - 19 Apr 2010

Abstract

Photoageing is generally treated by ablative procedures that injure the epidermis and basement membrane, and lead to fibrosis of the dermis. Percutaneous collagen induction (PCI) therapy is an alternative treatment for photoaged skin that does not result in clinical signs of dermal fibrosis. In this study, the immediate effects of PCI on the skin were assessed, including the systemic inflammatory response and the production and gene expression of transforming growth factor (TGF) isoforms β1, β2 and β3. Eighty rats were split into four groups: group 1 (n = 24; PCI plus skin care); group 2 (n = 24; skin care only); group 3 (n = 24; PCI only) and group 4 (n = 8; controls). Microarray analysis showed that TGF-β3, an essential marker for preventing scarring, was upregulated and expressed for 2 weeks postoperatively. PCI might offer a regenerative therapy to improve skin appearance and quality and to improve or even prevent scarring.

ASJC Scopus subject areas

Cite this

Percutaneous collagen induction. Scarless skin rejuvenation:fact or fiction? / Aust, M. C.; Reimers, K.; Gohritz, A. et al.
In: Clinical and Experimental Dermatology, Vol. 35, No. 4, 19.04.2010, p. 437-439.

Research output: Contribution to journalArticleResearchpeer review

Aust, MC, Reimers, K, Gohritz, A, Jahn, S, Stahl, F, Repenning, C, Scheper, T, Altintas, MA, Schwaiger, N, Redeker, J & Vogt, PM 2010, 'Percutaneous collagen induction. Scarless skin rejuvenation:fact or fiction?', Clinical and Experimental Dermatology, vol. 35, no. 4, pp. 437-439. https://doi.org/10.1111/j.1365-2230.2010.03779.x
Aust, M. C., Reimers, K., Gohritz, A., Jahn, S., Stahl, F., Repenning, C., Scheper, T., Altintas, M. A., Schwaiger, N., Redeker, J., & Vogt, P. M. (2010). Percutaneous collagen induction. Scarless skin rejuvenation:fact or fiction? Clinical and Experimental Dermatology, 35(4), 437-439. https://doi.org/10.1111/j.1365-2230.2010.03779.x
Aust MC, Reimers K, Gohritz A, Jahn S, Stahl F, Repenning C et al. Percutaneous collagen induction. Scarless skin rejuvenation:fact or fiction? Clinical and Experimental Dermatology. 2010 Apr 19;35(4):437-439. doi: 10.1111/j.1365-2230.2010.03779.x
Aust, M. C. ; Reimers, K. ; Gohritz, A. et al. / Percutaneous collagen induction. Scarless skin rejuvenation:fact or fiction?. In: Clinical and Experimental Dermatology. 2010 ; Vol. 35, No. 4. pp. 437-439.
Download
@article{1929d52b00784adc96fe98d8aa1fee70,
title = "Percutaneous collagen induction. Scarless skin rejuvenation:fact or fiction?",
abstract = "Photoageing is generally treated by ablative procedures that injure the epidermis and basement membrane, and lead to fibrosis of the dermis. Percutaneous collagen induction (PCI) therapy is an alternative treatment for photoaged skin that does not result in clinical signs of dermal fibrosis. In this study, the immediate effects of PCI on the skin were assessed, including the systemic inflammatory response and the production and gene expression of transforming growth factor (TGF) isoforms β1, β2 and β3. Eighty rats were split into four groups: group 1 (n = 24; PCI plus skin care); group 2 (n = 24; skin care only); group 3 (n = 24; PCI only) and group 4 (n = 8; controls). Microarray analysis showed that TGF-β3, an essential marker for preventing scarring, was upregulated and expressed for 2 weeks postoperatively. PCI might offer a regenerative therapy to improve skin appearance and quality and to improve or even prevent scarring.",
author = "Aust, {M. C.} and K. Reimers and A. Gohritz and S. Jahn and F. Stahl and C. Repenning and T. Scheper and Altintas, {M. A.} and N. Schwaiger and J. Redeker and Vogt, {P. M.}",
year = "2010",
month = apr,
day = "19",
doi = "10.1111/j.1365-2230.2010.03779.x",
language = "English",
volume = "35",
pages = "437--439",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

Download

TY - JOUR

T1 - Percutaneous collagen induction. Scarless skin rejuvenation:fact or fiction?

AU - Aust, M. C.

AU - Reimers, K.

AU - Gohritz, A.

AU - Jahn, S.

AU - Stahl, F.

AU - Repenning, C.

AU - Scheper, T.

AU - Altintas, M. A.

AU - Schwaiger, N.

AU - Redeker, J.

AU - Vogt, P. M.

PY - 2010/4/19

Y1 - 2010/4/19

N2 - Photoageing is generally treated by ablative procedures that injure the epidermis and basement membrane, and lead to fibrosis of the dermis. Percutaneous collagen induction (PCI) therapy is an alternative treatment for photoaged skin that does not result in clinical signs of dermal fibrosis. In this study, the immediate effects of PCI on the skin were assessed, including the systemic inflammatory response and the production and gene expression of transforming growth factor (TGF) isoforms β1, β2 and β3. Eighty rats were split into four groups: group 1 (n = 24; PCI plus skin care); group 2 (n = 24; skin care only); group 3 (n = 24; PCI only) and group 4 (n = 8; controls). Microarray analysis showed that TGF-β3, an essential marker for preventing scarring, was upregulated and expressed for 2 weeks postoperatively. PCI might offer a regenerative therapy to improve skin appearance and quality and to improve or even prevent scarring.

AB - Photoageing is generally treated by ablative procedures that injure the epidermis and basement membrane, and lead to fibrosis of the dermis. Percutaneous collagen induction (PCI) therapy is an alternative treatment for photoaged skin that does not result in clinical signs of dermal fibrosis. In this study, the immediate effects of PCI on the skin were assessed, including the systemic inflammatory response and the production and gene expression of transforming growth factor (TGF) isoforms β1, β2 and β3. Eighty rats were split into four groups: group 1 (n = 24; PCI plus skin care); group 2 (n = 24; skin care only); group 3 (n = 24; PCI only) and group 4 (n = 8; controls). Microarray analysis showed that TGF-β3, an essential marker for preventing scarring, was upregulated and expressed for 2 weeks postoperatively. PCI might offer a regenerative therapy to improve skin appearance and quality and to improve or even prevent scarring.

UR - http://www.scopus.com/inward/record.url?scp=77951235264&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2230.2010.03779.x

DO - 10.1111/j.1365-2230.2010.03779.x

M3 - Article

C2 - 20337652

AN - SCOPUS:77951235264

VL - 35

SP - 437

EP - 439

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 4

ER -

By the same author(s)